344 related articles for article (PubMed ID: 32623651)
1. Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis.
Guo LN; Nambudiri VE
Clin Rheumatol; 2021 Feb; 40(2):491-499. PubMed ID: 32623651
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
[TBL] [Abstract][Full Text] [Related]
6. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
Patel J; Borucki R; Werth VP
Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.
Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH
Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102
[TBL] [Abstract][Full Text] [Related]
8. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
9. Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review.
Kirchler C; Husar-Memmer E; Rappersberger K; Thaler K; Fritsch-Stork R
Autoimmun Rev; 2021 May; 20(5):102794. PubMed ID: 33722754
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
11. The classification and diagnosis of cutaneous lupus erythematosus.
Kuhn A; Landmann A
J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in cutaneous lupus.
Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little AJ; Vesely MD
Yale J Biol Med; 2020 Mar; 93(1):81-95. PubMed ID: 32226339
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Lupus Erythematosus: Progress and Challenges.
Petty AJ; Floyd L; Henderson C; Nicholas MW
Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
[TBL] [Abstract][Full Text] [Related]
18. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus.
Erazo-Martínez V; Tobón GJ; Cañas CA
Autoimmun Rev; 2023 Feb; 22(2):103262. PubMed ID: 36563771
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
Yazdani MR; Aflaki E; Gholijani N
Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of pediatric cutaneous lupus erythematosus: experience from a tertiary referral center in Korea.
Lee SK; Baek J; Roh JY; Kim HJ
Lupus; 2019 Jun; 28(7):888-892. PubMed ID: 31112454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
